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TRIBUTE TO PROFESSOR KAREN 
ROTHENBERG 
JACK SCHWARTZ, J.D.* 
If the life of the law is experience, as Holmes wrote1, what is a life in the 
law? To be exemplary, a life must consist not of experience in itself but rather 
experience catalyzed by learning, vision, and practical wisdom. This is Karen 
Rothenberg’s life in the law, embodying the standard of excellence. It’s been my 
good fortune to have participated in some key parts of her astonishingly broad 
range of accomplishments. 
I’ll begin with Karen’s vision about how to reshape the law on end-of-life 
medical care in Maryland. The basic story is that, prior to 1993, Maryland law 
was an ungainly combination of common law informed consent doctrine, living 
will legislation, a family “substituted consent” statute of uncertain scope, a 
general durable power of attorney statute, and the not-quite-law of a couple of 
Attorney General opinions. Especially after the Supreme Court’s Cruzan 
decision2 and the Maryland Court of Appeals’ Mack decision,3 a sense developed 
among key actors – judges, lawyers, physicians and other clinicians, advocates 
for the elderly and for people with disabilities – that a reform of the state’s health 
care decision-making law was badly needed. The concept was to produce a 
comprehensive statute that would address both planning documents and in-the-
moment decision making for the seriously ill. 
Some would-be reformers – me, for instance – were very cautious. We 
wanted to fix what we could but were worried that seeking too much change too 
soon, against what was sure to be strong opposition, would not survive the 
legislative process, leaving us stuck with the unsatisfactory status quo. This 
cautious approach, while defensible given the ethical debates of the time and the 
uncertain politics of the issue in the General Assembly, led to a proposal with 
only narrow changes on especially contested issues like the scope of family 
decision-making authority when the patient lacked capacity and hadn’t prepared 
an advance directive. But Karen, with her brilliant partner Diane Hoffmann, had 
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 1. Oliver Wendell Holmes, Jr., The Common Law 1 (1881) (“The life of the law has not been logic: 
it has been experience.”). 
 2. Cruzan v. Director, Missouri Dep’t of Health, 497 U.S. 261 (1990). 
 3. Mack v. Mack, 329 Md. 188, 618 A.2d 744 (1993). 
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the vision to see that a broad-based, activist, and tenacious coalition could 
achieve a more sweeping reform. 
Two bills emerged in the 1993 legislative session. One bill, largely drafted 
by circumspect insiders, reflected wariness about expanding advance directives 
and surrogate decision making. The other was bolder in its policy objectives and 
more capacious in its drafting. It was the work of a coalition, orchestrated by 
Karen and Diane, that benefited from its energy and diversity – important 
advocacy organizations like the Alzheimer’s Association and AARP, 
extraordinary Legal Aid lawyers, clinicians, legal and ethical scholars, and 
individuals with emotional stories to tell about their ill or injured loved ones. 
Karen had a better reading of the legislative and public mood at a time when end-
of-life policy making was in flux, and the coalition bill became the template for 
the ultimate compromise, which brought all of us together to push for enactment 
of what became the Maryland Health Care Decisions Act of 1993. She also 
foresaw how once-controversial provisions, like allowing advance directives and 
surrogate decision making to address treatment choices during the downward 
slope of serious illnesses even before the time of active dying, would become an 
accepted part of the way medicine is practiced in Maryland. Consequently, for a 
quarter-century the Health Care Decisions Act has been the legal armature for 
patient-centered care in the state and has influenced policy makers elsewhere 
who seek to make the law an ally of those providing excellent care near the end 
of life. 
The foundation of Karen’s health policy advocacy, as of her teaching, has 
always been her scholarship. Sometimes the audience for her scholarship is not 
peers in the academy or law school students but appellate judges. Here my 
favorite example is the stern lecture Karen and Diane delivered to the Maryland 
Court of Appeals after its egregious decision in Grimes v. Kennedy Krieger,4 a 
case involving alleged negligence in a research project to compare methods of 
ameliorating lead exposure in inner-city housing. Venturing far beyond the needs 
of the case or the court’s institutional competence, the court majority provided 
an account of the research enterprise and the duty of researchers that was 
tendentious, inexact, and troubling. Karen and Diane produced a 
“deconstruction” of the opinion that laid bare its frailty and offered an alternative 
understanding of a researcher’s duty that would both reduce the threat to public 
health research caused by the court’s lax reasoning and protect research 
participants.5 (This was far from the only sin against judicial modesty in the 
Grimes opinion, but Karen and Diane would have had to write a novella to deal 
with all of them.) 
 
 4. 366 Md. 29, 782 A.2d 807 (2001). 
 5. Diane E. Hoffmann and Karen H. Rothenberg, Whose Duty Is It Anyway?: The Kennedy Krieger 
Opinion and Its Implications for Public Health Research, 6 J. Health Care L & Pol’y 109 (2002). 
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Practical wisdom: a good example is Karen’s approach to Maryland’s 
funding of stem cell research. In 2006, the Maryland General Assembly, 
responding to stringent limitations on federal grants for embryonic stem cell 
research, created a fund to support what was then an infant biotechnology. Karen 
was first a member and then chair of the commission to superintend the 
distribution of the funds. 
Maryland wasn’t the first state to fund stem cell research. Two years earlier, 
the California Institute for Regenerative Medicine (CIRM) was created. From its 
inception, CIRM supporters made lofty promises about cures. When the slow 
pace of basic and translational research did not yield the predicted breakthroughs, 
CIRM was dogged by controversy. Karen had the discernment to know that the 
best path forward for the Maryland effort would be, by contrast, quiet and 
steadfast professionalism – a scientifically sound grant review process, free of 
conflicts of interest and political agendas, with criteria to encourage young 
scientists and not just already established figures. No hyperbole, no culture war 
rhetoric. Working with other members of the Maryland Stem Cell Research 
Commission and the staff of the Maryland Technology Development 
Corporation, Karen assured that Maryland would become a leader in supporting 
this leading-edge research domain. Although funding has waned since the early 
years, the path Karen set has resulted in a stem-cell research community among 
the best in the country.  
These three aspects of health law and policy are only a few fragments of 
Karen’s career. Others can better speak of her law school leadership; the range 
of her scholarship, especially on genetics and women’s health; the creativity of 
her publicly oriented pedagogy, including her recent foray into playwriting; and 
her building of bridges to other institutions, notably the National Institutes of 
Health and the John Hopkins Berman Institute of Bioethics. But these examples, 
chosen from decades of collaboration, illuminate the qualities that have made her 
a preeminent figure in Maryland and nationally – an exemplar of life in the law 
to the fullest. 
 
